Works matching IS 17762596 AND DT 2024 AND VI 19 AND IP 5

Results: 16

Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 769, doi. 10.1007/s11523-024-01092-7

By:

Sho, Takuya;
Suda, Goki;
Ohara, Masatsugu;
Kohya, Risako;
Sasaki, Takashi;
Yoshida, Sonoe;
Hosoda, Shunichi;
Ogawa, Koji;
Kitagataya, Takashi;
Maehara, Osamu;
Ohnishi, Shunsuke;
Kawagishi, Naoki;
Natsuizaka, Mitsuteru;
Nakai, Masato;
Baba, Masaru;
Yamamoto, Yoshiya;
Tsukuda, Yoko;
Meguro, Takashi;
Yamada, Ren;
Kobayashi, Tomoe

Publication type:

Article

A Phase 1a/1b Dose Escalation/Expansion Study of the Anti-PD-1 Monoclonal Antibody Nofazinlimab in Chinese Patients with Solid Tumors or Lymphoma.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 723, doi. 10.1007/s11523-024-01091-8

By:

Gong, Jifang;
Guo, Ye;
Zhang, Yanqiao;
Ba, Yi;
Chen, Tong;
Li, Wei;
Zhou, Caicun;
Wang, Mengzhao;
Yang, Haiyan;
Zhou, Yuhong;
Cai, Qiqing;
Wang, Ziping;
Huang, Gang;
Zhang, Wei;
Su, Rila;
Cai, Zhongheng;
Yue, Zenglian;
Dou, Jinzhou;
Li, Peiqi;
Wu, Rachel

Publication type:

Article

lnsights into Adjuvant Systemic Treatment Selection for Patients with Stage III Melanoma: Data from the Dutch Cancer Registry.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 735, doi. 10.1007/s11523-024-01090-9

By:

Aldenhoven, Loeki;
van Weezelenburg, Merel A. Spiekerman;
van den Berkmortel, Franchette W. P. J.;
Servaas, Nick;
Janssen, Alfred;
Vissers, Yvonne L. J.;
van Haaren, Elisabeth R. M.;
Beets, Geerard L.;
van Bastelaar, James

Publication type:

Article

Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 747, doi. 10.1007/s11523-024-01089-2

By:

Rizzo, Alessandro;
Monteiro, Fernando Sabino Marques;
Ürün, Yüksel;
Massari, Francesco;
Park, Se Hoon;
Bourlon, Maria T.;
Poprach, Alexandr;
Rizzo, Mimma;
Takeshita, Hideki;
Giannatempo, Patrizia;
Soares, Andrey;
Roviello, Giandomenico;
Molina-Cerrillo, Javier;
Carrozza, Francesco;
Abahssain, Halima;
Messina, Carlo;
Kopp, Ray Manneh;
Pichler, Renate;
Formisano, Luigi;
Tural, Deniz

Publication type:

Article

Identifying Actionable Alterations in KRAS Wild-Type Pancreatic Cancer.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 679, doi. 10.1007/s11523-024-01088-3

By:

Elhariri, Ahmed;
Patel, Jaydeepbhai;
Mahadevia, Himil;
Albelal, Douaa;
Ahmed, Ahmed K.;
Jones, Jeremy C.;
Borad, Mitesh J.;
Babiker, Hani

Publication type:

Article

Patient Enrollment per Month (Accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 797, doi. 10.1007/s11523-024-01081-w

By:

Michaeli, Daniel Tobias;
Michaeli, Thomas;
Albers, Sebastian;
Michaeli, Julia Caroline

Publication type:

Article

Correction to: Moving T‑Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review.

Published in:

2024

By:

Fowler, Nathan Hale;
Chavez, Julio C.;
Riedell, Peter A.

Publication type:

Correction Notice

Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 757, doi. 10.1007/s11523-024-01084-7

By:

Matsumoto, Kinnosuke;
Yamamoto, Yuji;
Shiroyama, Takayuki;
Kuge, Tomoki;
Mori, Masahide;
Tamiya, Motohiro;
Kinehara, Yuhei;
Tamiya, Akihiro;
Suzuki, Hidekazu;
Tobita, Satoshi;
Ueno, Kiyonobu;
Niki, Toshie;
Nagatomo, Izumi;
Takeda, Yoshito;
Kumanogoh, Atsushi

Publication type:

Article

Author's Reply to Ma et al.: "Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis".

Published in:

2024

By:

Maiorano, Brigida Anna;
Necchi, Andrea;
Di Maio, Massimo

Publication type:

Letter

Comment on: "Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta‑analysis".

Published in:

2024

By:

Ma, Jun;
Han, Wei

Publication type:

Letter

An Evidence-Based Rationale for Dose De-escalation of Subcutaneous Atezolizumab.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 779, doi. 10.1007/s11523-024-01087-4

By:

Kicken, Mart P.;
Deenen, Maarten J.;
Moes, Dirk J. A. R.;
Hendrikx, Jeroen J. M. A.;
van den Borne, Ben E. E. M.;
Dumoulin, Daphne W.;
van der Wekken, Anthonie J.;
van den Heuvel, Michiel M.;
ter Heine, Rob

Publication type:

Article

Current State of Targeted Therapy in Adult Langerhans Cell Histiocytosis and Erdheim–Chester Disease.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 691, doi. 10.1007/s11523-024-01080-x

By:

Lin, He;
Cao, Xin-xin

Publication type:

Article

Malignant Peripheral Nerve Sheath Tumor, a Heterogeneous, Aggressive Cancer with Diverse Biomarkers and No Targeted Standard of Care: Review of the Literature and Ongoing Investigational Agents.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 665, doi. 10.1007/s11523-024-01078-5

By:

Somaiah, Neeta;
Paudyal, Bishnuhari;
Winkler, Robert E.;
Van Tine, Brian A.;
Hirbe, Angela C.

Publication type:

Article

Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical Trial.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 711, doi. 10.1007/s11523-024-01076-7

By:

Salawu, Abdulazeez;
Malone, Eoghan R.;
Al-Ezzi, Esmail;
Genta, Sofia;
Vornicova, Olga;
Wang, Lisa;
Arones, Limore;
Phillips, Madeline;
Lee, Jasmine;
Watson, Geoffrey A.;
Gupta, Abha A.;
Abdul Razak, Albiruni R.

Publication type:

Article

Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 789, doi. 10.1007/s11523-024-01075-8

By:

Moes, Dirk J. A. R.;
Hendrikx, Jeroen J. M. A.;
Guchelaar, Henk-Jan;
Mathijssen, Ron H. J.;
Bakker, J. L.;
Dezentjé, Vincent O.;
de Rouw, Nikki;
van Erp, Nielka P.;
Smit, Egbert F.;
van den Heuvel, Michel M.;
Munnink, Thijs H. Oude;
van Kats, Maartje;
Croes, Sander;
Kroep, Judith R.;
Zwaveling, Juliette;
ter Heine, Rob

Publication type:

Article

Trastuzumab-Deruxtecan: Redefining HER2 as a Tumor Agnostic Biomarker.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 705, doi. 10.1007/s11523-024-01079-4

By:

Zouein, Joseph;
Karam, Elias;
Strickler, John H.;
Kourie, Hampig Raphael

Publication type:

Article